We serve Chemical Name:[(2R,3S,4R,5R,6S)-5-acetamido-3,4-diacetyloxy-6-(4-nitrophenoxy)oxan-2-yl]methyl acetate CAS:13089-27-5 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
![[(2R,3S,4R,5R,6S)-5-acetamido-3,4-diacetyloxy-6-(4-nitrophenoxy)oxan-2-yl]methyl acetate](https://a.dearchem.com/CAS2/13089-27-5.png)
Chemical Name:[(2R,3S,4R,5R,6S)-5-acetamido-3,4-diacetyloxy-6-(4-nitrophenoxy)oxan-2-yl]methyl acetate
CAS.NO:13089-27-5
Synonyms:p-Nitrophenyl 2-Acetamido-3,4,6-tri-O-acetyl-|A-D-glucopyranoside;p-Nitrophenyl 2-Acetamido-2-deoxy-|A-D-glucopyranoside Triacetate;W0321
Molecular Formula:C20H24N2O11
Molecular Weight:468.41100
HS Code:
Physical and Chemical Properties:
Melting point:N/A
Boiling point:N/A
Density:N/A
Index of Refraction:1.55
PSA:172.28000
Exact Mass:468.13800
LogP:1.54380
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:
Contact us for information like p-Nitrophenyl 2-Acetamido-3,4,6-tri-O-acetyl-|A-D-glucopyranoside chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,W0321 physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,p-Nitrophenyl 2-Acetamido-2-deoxy-|A-D-glucopyranoside Triacetate Use and application,p-Nitrophenyl 2-Acetamido-2-deoxy-|A-D-glucopyranoside Triacetate technical grade,usp/ep/jp grade.
Related News: Pharmaceutical intermediates and APIs belong to the fine chemical industry. [(2R,3S,4R,5R,6S)-5-acetamido-3,4-diacetyloxy-6-(4-nitrophenoxy)oxan-2-yl]methyl acetate manufacturer The clinical trial International Study of Phase 3 IV RigosErtib, or INSPIRE, was finalized following guidance received from the U.S. Food and Drug Administration and European Medicines Agency. [(2R,3S,4R,5R,6S)-5-acetamido-3,4-diacetyloxy-6-(4-nitrophenoxy)oxan-2-yl]methyl acetate supplier The clinical trial International Study of Phase 3 IV RigosErtib, or INSPIRE, was finalized following guidance received from the U.S. Food and Drug Administration and European Medicines Agency. [(2R,3S,4R,5R,6S)-5-acetamido-3,4-diacetyloxy-6-(4-nitrophenoxy)oxan-2-yl]methyl acetate vendor Bristol-Myers Squibb (BMS) recently acquired Celgene, for example, which had the highest proportional R&D spend. [(2R,3S,4R,5R,6S)-5-acetamido-3,4-diacetyloxy-6-(4-nitrophenoxy)oxan-2-yl]methyl acetate factory Bristol-Myers Squibb (BMS) recently acquired Celgene, for example, which had the highest proportional R&D spend.
